Alzheimer’s prevention hope as drug cuts deadly disease onset in half
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in people with a genetic predisposition to the devastating condition. Right now, symptoms are almost 100% likely to develop in patients betwe…
{"error": "429 Resource has been exhausted (e.g. check quota)."}